ArticleFrontiers in microbiology2024
Antimicrobial resistance and genomic analysis of
Article in Frontiers in microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Genomic Dissection Reveals Polyphyletic Origins and Recombination-Driven Diversification of O/K Antigen Loci in FoodborneMicroorganisms · 2026Article
- Molecular epidemiological analysis ofFrontiers in public health · 2026Article
- Genomic and resistome characterization of a multidrug-resistantFrontiers in microbiology · 2026Article
- Induction of the viable but non-culturable state by an alkyl dipropylene triamine-based disinfectant in Vibrio parahaemolyticus biofilms.Scientific reports · 2025Article
- Prevalence and Genomic Characterization ofFoods (Basel, Switzerland) · 2025Article
- Epidemiological characteristics, virulence genes, and antimicrobial resistance analysis ofFrontiers in microbiology · 2025Article
- Antimicrobial Resistance and Genomic Characterization of Salmonella Serovars Typhimurium and 4,[5],12:i:- in Huzhou, China.Infection and drug resistance · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The purpose of this study was to investigate the epidemiological and genomic characteristics of Methods: This study aims to analyze the epidemiological data on Results: Most outbreaks of Conclusion: The newly emerged serotype O10:K4 became dominant from 2021 to 2023, with most isolates being ST3. PFGE and WGS technologies provided reliable methods for typing and identifying
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.